⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

Official Title: Phase II, Open, Single Group, Multicentre Study to Evaluate the Efficacy and Safety of Lanreotide Autogel Administered Every 4 Weeks by Deep Subcutaneous Injection in the Tumour's Growth Stabilization of Patients With Progressive Neuroendocrine Tumours Who Are Not Eligible to be Treated With Either Surgery or Chemotherapy

Study ID: NCT00326469

Conditions

Neuroendocrine Tumours

Interventions

lanreotide (Autogel formulation)

Study Description

Brief Summary: To evaluate, in patients with progressive neuroendocrine tumours who are not eligible to be treated with either surgery or chemotherapy at the moment of study inclusion, the efficacy of lanreotide Autogel in tumour growth stabilization.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

H. Juan Canalejo, A Coruña, , Spain

H. Virgen de los Lirios, Alcoy, , Spain

H. General Univ. de Alicante, Alicante, , Spain

H. Germans Trias i Pujol, Badalona, , Spain

H. Santa Creu i Sant Pau, Barcelona, , Spain

H. Clínic i Provincial, Barcelona, , Spain

Corporación H. Parc Tauli, Barcelona, , Spain

Consorci Sanitari de Terrassa, Barcelona, , Spain

H. General de Hospitalet, Barcelona, , Spain

H. de Basurto, Bilbao, , Spain

H. General de Elche, Elche, , Spain

H. de la Princesa, Madrid, , Spain

H. Ramón y Cajal, Madrid, , Spain

H. Clínico Univ. San Carlos, Madrid, , Spain

H. 12 de Octubre, Madrid, , Spain

H. Severo Ochoa, Madrid, , Spain

Fundación H. Son Llàtzer, Palma de Mallorca, , Spain

Consorcio H. de Pontevedre, Pontevedra, , Spain

H. de Sagunto, Sagunto, , Spain

H. Clínico de Salamanca, Salamanca, , Spain

Int. Oncológico San Sebastián, San Sebastián, , Spain

H. Marques de Valdecilla, Santander, , Spain

H. Univ. de Canarias, Tenerife, , Spain

Hospital Universitario "Dr. Peset", Valencia, , Spain

H. La Fe, Valencia, , Spain

H. Hospital General Universitario de Valencia, Valencia, , Spain

H. Miguel Servet, Zaragoza, , Spain

Contact Details

Name: Ipsen Medical Director

Affiliation: Ipsen

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: